Delivery Order SPE2DB25D3404-SPE2DB25FUPKV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,747.38 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ebglyss 250 mg/2 ml pen (2 ml). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this award...
- The Defense Logistics Agency awarded a delivery order valued at $2,860.57 to AmerisourceBergen Drug Corp for Ebglyss 250 mg/2 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.93 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ebyglss 250 mg/2 ml pen (2 ml). This firm fixed-price, competitively awarded contract involves a non-set-aside procurement and is scheduled for completion by July 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,534.57, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ebyglss 250 mg/2 mL pen (2 mL) with a ceiling value of $4,121.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,885.03 to AmerisourceBergen Drug Corp for Ebylass 250 mg/2 ml pen (2 ml), a pharmaceutical product for federal medical procurement. The contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency awarded a delivery order valued at approximately $2,977 to AmerisourceBergen Drug Corp for Ebygloss 250 mg/2 mL pen medication on August 4, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is structured as a child contract under a larger vehicle, leveraging the company's existing federal procurement relationship to supply...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, EBGLYSS 250 MG/2 ML PEN 2ML, with a firm fixed price of $1,819.44 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $126,953.03 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply deliveries to support federal healthcare operations. This firm fixed price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of July 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award was made through...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPKVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,700.74 to AmerisourceBergen Drug Corp for EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product for federal medical supply needs. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's substantial IDC with DLA enables it to fulfill orders for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents one of numerous transactions under that prime contract vehicle, demonstrating the company's ongoing role in supporting federal medical procurement requirements through competitively awarded mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/24/25 |